Concentric Analgesics Stock

concentricanalgesics.comHealthcare / BioTech & PharmaFounded: 2014Funding to Date: $85.36MM

Concentric Analgesics is a biotechnology company focused on discovering and developing novel, non-opioid therapeutics for the management of acute and chronic pain.

Register for Details

For more details on financing and valuation for Concentric Analgesics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Concentric Analgesics.

Register Today

Team

Management Team

John Donovan MD
Co-Founder, President & Board Member
Mike Royal MD
Chief Medical Officer
Frank Bellizzi Jr.
Chief Executive Officer & Board Member
Thomas King
Executive Chairman & Board Member
Ryan Daws
Chief Financial Officer
Craig Husfeld Ph.D
Co-Founder, Chief Scientific Officer & Board Member

Board Members

Craig Husfeld Ph.D
Thomas King
Frank Bellizzi Jr.
John Donovan MD

Other companies like Concentric Analgesics in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.74B
Updated on: Oct 2, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.